Arcus Biosciences Inc

Overview

Arcus Biosciences Inc (Arcus Biosciences) operates as a clinical stage bio-pharmaceutical company focused on creating innovative cancer immunotherapies by leveraging underexploited biological opportunities. Its product pipeline includes AB928, a selective dual antagonist of the adenosine receptors known as A2aR and A2bR in combination with anti-PD-1 antibody (AB122) and chemotherapy are used for the treatment of metastatic triple-negative breast cancer or ovarian cancer and advanced malignancies; AB122, an anti-PD-1 antibody targeting cancer; AB154, an anti-TIGIT antibody; and AB680, a CD73 inhibitor against solid tumors. The company has in-house specialization in medicinal chemistry, immunology, biochemistry, pharmacology and structural biology. Arcus Biosciences is headquartered in Hayward, California, the US.
Key Stats
Address
3928 Point Eden Way, HAYWARD, California
Headquarters

United States of America

Contact

1 510 6946200

No of Employees

236

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

RCUS [NYSE]

Revenue (2020)

$78 m

420% (2020 vs 2019)
Net Income (2020)

$-123 m

-45.2% (2020 vs 2019)
Net Profit Margin

-158 %

71.9% (2020 vs 2019)
Market Cap *

$2,397 m

EPS *

$-2.2

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Arcus Biosciences IncAthenex IncCogent Biosciences Inc
Key Information
Headquarters United States of America United States of America United States of America
Headquarter City HAYWARD BUFFALO CAMBRIDGE
Headquarter State/Province California New York Massachusetts
No. of Employees 236 593 15
Entity Type Public Public Public

Products & Services

Arcus Biosciences is a clinical stage bio-pharmaceutical company. The key products of the company include the following

Products
  • Pipeline
  • AB928:
  • Metastatic Triple-Negative Breast Cancer or Ovarian Cancer
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2020 Contracts/Agreements In January, the company and Surface Oncology Inc entered into an agreement to treat people…
2020 Contracts/Agreements In December, the company entered into a strategic relationship with WuXi Biologics to develop anti-CD39…
2020 Contracts/Agreements In October, the company and AstraZeneca entered into a partnership to evaluate the combination therapy…
2020 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2019 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Arcus Biosciences Australia Pty Ltd

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
01 Feb 2021 Arcus Biosciences Raises USD220.4 Million in Private Placement of Shares Equity Offering Gilead Sciences Inc Arcus Biosciences Inc
09 Dec 2020 Arcus Biosciences Enters into Agreement with WuXi Biologics Partnership Arcus Biosciences Inc; WuXi Biologics (Hong Kong) Ltd
29 Oct 2020 Arcus Biosciences Enters into Collaboration with AstraZeneca Partnership Arcus Biosciences Inc; AstraZeneca Plc
27 Oct 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
27 Oct 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
27 Oct 2020 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

56

Active Jobs

0

Posted

0

Closed

Job Trends

Latest Jobs

Job title Company Country
Associate Director/Director Quality Assurance (Antibody Quality Operations) Arcus Biosciences Inc United States
Director /Sr. Director Quality Assurance (Small Molecule Quality Operations) Arcus Biosciences Inc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar